Product Images Cyclobenzaprine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Cyclobenzaprine Hydrochloride NDC 70518-3814 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
MM2 - Cyclobenzaprine HCl 5mg 70518 3814 01
This is a description of Cyclobenzaprine HCI, a medication available in tablet form with a strength of 5 mg. The quantity provided is 90 tablets. The tablets are repackaged by RemedyRepack Inc. and the original manufacturer is Advagen Pharma Limited. The tablets should be kept out of the reach of children. The directions for use can be found in the package insert. The medication should be stored at a temperature between 20-25°C (88-77°F), with excursions permitted between 15-30°C (59-86°F) according to USP guidelines.*
Remedy_Label - Remedy Label
This is a package of Cyclobenzaprine HCI tablets containing 5 mg each. There are 30 tablets in the package. The tablets are intended for prescription use only. The NDC number is 70518-3814-00. The manufacturer is Advagen Pharma Limited located in Plainsboro, NJ 08536. The medication should be kept out of reach of children. Directions for use can be found in the package insert. The tablets should be stored at a temperature between 20-25°C (88-77°F), with excursions permitted between 15-30°C (59-86°F) according to USP guidelines. The packaging has been done by RemedyRepack Inc., located in Indiana, PA 15701.*
Image - cyclobenzaprine hcl tabs structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
